BDBM50041654 (S)-3-{[(S)-2-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)-propionylamino]-6-((E)-3-pyridin-3-yl-acryloylamino)-hexanoyl]-methyl-amino}-N-((S)-1-carbamoyl-2-phenyl-ethyl)-N-methyl-succinamic acid::CHEMBL289284

SMILES CN([C@@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O)C(=O)[C@H](CCCCNC(=O)C=Cc1cccnc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C

InChI Key InChIKey=USWDPRRJNGKNQG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50041654   

TargetGastrin/cholecystokinin type B receptor(Human)
Abbott Laboratories

Curated by ChEMBL
LigandPNGBDBM50041654((S)-3-{[(S)-2-[2-tert-Butoxycarbonylamino-3-(1H-in...)
Affinity DataIC50: 2.27E+4nMAssay Description:In vitro binding for half maximal inhibition of [125I]- cholecystokinin type B receptor in guinea pig cortexMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2012
Entry Details Article
PubMed